Pulsatilla Saponin D: the Antitumor Principle from Pulsatilla koreana |
Kim, Yong
(SB Pharmaceutical Co. LTD)
Bang, Seong-Cheol (SB Pharmaceutical Co. LTD) Lee, Ji-Hyun (SB Pharmaceutical Co. LTD) Ahn, Byung-Zun (SB Pharmaceutical Co. LTD) |
1 | Campbell, W. E., Cragg, G. M. L., and Powrie, A. H., Anemonin, protoanemonin and ranunculin from Knowltonia capensis. Phytochemistry, 18, 323-324 (1979) DOI ScienceOn |
2 | Martin, M. L., San Roman, L., and Dominguez, A., In vitro activity of protoanemonin, an antifungal agent. Planta Med., 56, 66-69 (1990) DOI ScienceOn |
3 | Ye, W. C., Ou, B. X., Ji, N. N., Zhao, S. X., Ye, T., Anthony, M. K., and Paul, S., Patensin, a saponin from Pulsatilla patens var. multifida. Phytochemistry, 39 (4), 937-939 (1995) DOI ScienceOn |
4 | Kang, S. S., Saponins from the root of Pulsatilla koreana. Arch. Pharm. Res., 12, 42-47 (1989) DOI ScienceOn |
5 | Yoshihiro M., Akihito Y., Minpei K., Tomoki A., and Yutaka S., Triterpene saponins and lignans from the root Pulsatilla chinensis and their cytotoxic activity against HL-60 cells. J. Nat. Prod., 62, 1279-1283 (1999) DOI ScienceOn |
6 | Kim, Y., Kim, S. B., You, Y. J., and Ahn, B. Z., Deoxypodophyllotoxin; The cytotoxic and antiangiogenic component from Pulsatilla koreana. Planta Med., 68, 268-271 (2002) DOI ScienceOn |
7 | Kim, S. Y. and Kim, S. B., Anti-tumor effects of extracts of Pulsatilla koreana () in vitro. J. Kor. Cancer Assoc., 26 (6), 959-963 (1994) |
8 | Teruhiro U, Jiro S, Yoshikazu S, Kumio A, and Yuji Y, Antitumor activity of a novel podophylotoxin derivatives (TOP53) against lung cancer and lung matastatic cancer. Cancer Res., 56, 2809-2814 (1996) PUBMED |
9 | Viqar U. A., Spectroscopic data of saponins. CRC Press, 1469 (2000) |
10 | Kim, Y., You, Y., J., Bang, S. C., Lee, C. W., Kim, H. M., and Ahn, B. Z., In vivo, antitumor activity of injection. Phytother. Res. (2004, submitted) |
11 | Bae, K. H., The medicinal plants of Korea. Kyo-Hak Press, 139 (1999) |
12 | Li, R. Z. and Ji, X. J., The cytotoxicity and action mechanism of Ranunculin in vitro. Yao Hsueh Hsueh Pao, 28, 326-331 (1993) |
13 | Skehan P, Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J. T., Bokesh H., Kenney S., and Boyd M. R., Feasibility of a highly-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst., 82, 1107-1112 (1990) DOI PUBMED |